The Department of Labour has published a new directive around its Covid-19 Temporary Employee/Temporary Employer Scheme

Loading player...
Gugu Mfuphi talks to Andrew Levy, Labour Analyst about The Department of Labour has published a new directive around its Covid-19 Temporary Employee/Temporary Employer Scheme (TERS), introducing a number of new amendments and regulations for South African businesses.
The TERS is one of the key measures that government is using to financially support employers and employees during the coronavirus lockdown, with the new directive providing further clarification on the new scheme and the rights of employers and employees.
Below law firm Werksmans outlined the salient aspects of the TERS and how the new amendments impact the labour market.
 The benefit an employee can receive under this scheme will be capped to a maximum amount of R6 730.56 per month per employee. The maximum salary to be taken into account in calculating the benefits will be R17,712.00 per month and the employee will be paid in terms of the income replacement sliding scale (38%-60%) as provided for in the Unemployment Insurance Act.
15 Apr 2020 12PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min